跳至主要内容
临床试验/CTRI/2023/05/052423
CTRI/2023/05/052423尚未招募2 期

A PROSPECTIVE OPEN LABELLED, SINGLE ARM, NON-RANDOMIZED, SINGLE CENTRIC, PHASE II CLINICAL TRIAL TO DETERMINE THE EFFECTIVENESS OF THOTTAR CHINUNGI CHOORANAM IN THE MANAGEMENT OF MADHUMEGA NOI (DIABETES MELLITUS

Government Siddha Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • •1.Patients with symptoms of polyuria, polydipsia, polyphagia,asthenia, nocturia, obesity(metabolic syndrome),numbness,tingling sensation,mood changes and irritability difficulty in concentration.
  • •2.Even if patients is having any one among the three (WHO criteria 2019)
  • •a. FBS >126mg/dl and <250 mg/dl or
  • •b. PBS >200 mg/dl and <350 mg/dl or
  • •c. HbA1c >6.5 and <10

排除标准

  • •1.Age below 34 years and above 60 years
  • •2.Type I diabetes mellitus
  • •3.Gestational diabetes
  • •4.Diabetes insipidus
  • •5.Pregnancy
  • •6.Lactating mother
  • •7.Chronic kidney disease
  • •7.Ischemic heart disease

研究者

发起方
Government Siddha Medical College and Hospital

相似试验